BET inhibitor OTX015 targets BRD2 and BRD4 and decreases c-MYC in acute leukemia cells

被引：216

作者：

Coude, Marie-Magdelaine ^{[1
,2
,3
]}

Braun, Thorsten ^{[1
,4
,5
]}

Berrou, Jeannig ^{[1
]}

Dupont, Melanie ^{[1
]}

Bertrand, Sibyl ^{[1
]}

Masse, Aline ^{[1
]}

Raffoux, Emmanuel ^{[1
,3
,6
]}

Itzykson, Raphael ^{[1
,3
,6
]}

Delord, Marc ^{[7
]}

Riveiro, Maria E. ^{[8
]}

Herait, Patrice ^{[9
]}

Baruchel, Andre ^{[1
,3
,10
]}

Dombret, Herve ^{[1
,3
,6
]}

Gardin, Claude ^{[1
,4
,5
]}

机构：

[1] Univ Paris 07, Inst Univ Hematol, Lab Transfert Leucemies, Paris, France

[2] Hop St Louis, Assistance Publ Hop Paris, Hematol Lab, Paris, France

[3] Univ Paris 07, Paris, France

[4] Hop Avicenne, Assistance Publ Hop Paris, Dept Hematol, F-93009 Bobigny, France

[5] Univ Paris 13, Bobigny, France

[6] Hop St Louis, Assistance Publ Hop Paris, Leukemia Unit, Dept Hematol, Paris, France

[7] Univ Paris 07, Inst Univ Hematol, Bioinformat, Paris, France

[8] Oncol Therapeut Dev, Clichy, France

[9] Oncoethix, Lausanne, Switzerland

[10] Hop Robert Debre, Assistance Publ Hop Paris, Dept Pediat Hematoimmunol, F-75019 Paris, France

来源：

ONCOTARGET | 2015年 / 6卷 / 19期

关键词：

OTX015; BET inhibitors; c-MYC; HEXIM1; acute leukemias; ACUTE MYELOID-LEUKEMIA; ACUTE LYMPHOBLASTIC-LEUKEMIA; POLYMERASE-II TRANSCRIPTION; P-TEFB; BROMODOMAIN INHIBITION; RNA; MECHANISM; HEXIM1; GENE; DIFFERENTIATION;

D O I：

10.18632/oncotarget.4131

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

The bromodomain (BRD) and extraterminal (BET) proteins including BRD2, BRD3 and BRD4 have been identified as key targets for leukemia maintenance. A novel oral inhibitor of BRD2/3/4, the thienotriazolodiazepine compound OTX015, suitable for human use, is available. Here we report its biological effects in AML and ALL cell lines and leukemic samples. Exposure to OTX015 lead to cell growth inhibition, cell cycle arrest and apoptosis at submicromolar concentrations in acute leukemia cell lines and patient-derived leukemic cells, as described with the canonical JQ1 BET inhibitor. Treatment with JQ1 and OTX15 induces similar gene expression profiles in sensitive cell lines, including a c-MYC decrease and an HEXIM1 increase. OTX015 exposure also induced a strong decrease of BRD2, BRD4 and c-MYC and increase of HEXIM1 proteins, while BRD3 expression was unchanged. c-MYC, BRD2, BRD3, BRD4 and HEXIM1 mRNA levels did not correlate however with viability following exposure to OTX015. Sequential combinations of OTX015 with other epigenetic modifying drugs, panobinostat and azacitidine have a synergic effect on growth of the KASUMI cell line. Our results indicate that OTX015 and JQ1 have similar biological effects in leukemic cells, supporting OTX015 evaluation in a Phase Ib trial in relapsed/refractory leukemia patients.

引用

页码：17698 / 17712

页数：15

共 40 条

[11] BET Bromodomain Inhibition as a Therapeutic Strategy to Target c-Myc [J].

Delmore, Jake E. ;

Issa, Ghayas C. ;

Lemieux, Madeleine E. ;

Rahl, Peter B. ;

Shi, Junwei ;

Jacobs, Hannah M. ;

Kastritis, Efstathios ;

Gilpatrick, Timothy ;

Paranal, Ronald M. ;

Qi, Jun ;

Chesi, Marta ;

Schinzel, Anna C. ;

McKeown, Michael R. ;

Heffernan, Timothy P. ;

Vakoc, Christopher R. ;

Bergsagel, P. Leif ;

Ghobrial, Irene M. ;

Richardson, Paul G. ;

Young, Richard A. ;

Hahn, William C. ;

Anderson, Kenneth C. ;

Kung, Andrew L. ;

Bradner, James E. ;

Mitsiades, Constantine S. .

CELL, 2011, 146 (06) :903-916

[12] HEXIM1 and the control of transcription elongation: From cancer and inflammation to AIDS and cardiac hypertrophy [J].

Dey, Anwesha ;

Chao, Sheng-Hao ;

Lane, David P. .

CELL CYCLE, 2007, 6 (15) :1856-1863

[13] 7SK RNA, a non-coding RNA regulating P-TEFb, a general transcription factor [J].

Diribarne, Gaelle ;

Bensaude, Olivier .

RNA BIOLOGY, 2009, 6 (02) :122-128

[14] Identification of a novel BET bromodomain inhibitor-sensitive, gene regulatory circuit that controls Rituximab response and tumour growth in aggressive lymphoid cancers [J].

Emadali, Anouk ;

Rousseaux, Sophie ;

Bruder-Costa, Juliana ;

Rome, Claire ;

Duley, Samuel ;

Hamaidia, Sieme ;

Betton, Patricia ;

Debernardi, Alexandra ;

Leroux, Dominique ;

Bernay, Benoit ;

Kieffer-Jaquinod, Sylvie ;

Combes, Florence ;

Ferri, Elena ;

McKenna, Charles E. ;

Petosa, Carlo ;

Bruley, Christophe ;

Garin, Jerome ;

Ferro, Myriam ;

Gressin, Remy ;

Callanan, Mary B. ;

Khochbin, Saadi .

EMBO MOLECULAR MEDICINE, 2013, 5 (08) :1180-1195

[15] Acute myeloid leukaemia [J].

Estey, Elihu ;

Doehner, Hartmut .

LANCET, 2006, 368 (9550) :1894-1907

[16]

French CA, 2003, CANCER RES, V63, P304

[17] BET bromodomain inhibitors: a patent review [J].

Garnier, Jean-Marc ;

Sharp, Phillip P. ;

Burns, Christopher J. .

EXPERT OPINION ON THERAPEUTIC PATENTS, 2014, 24 (02) :185-199

[18] MYC, a downstream target of BRD-NUT, is necessary and sufficient for the blockade of differentiation in NUT midline carcinoma [J].

Grayson, A. R. ;

Walsh, E. M. ;

Cameron, M. J. ;

Godec, J. ;

Ashworth, T. ;

Ambrose, J. M. ;

Aserlind, A. B. ;

Wang, H. ;

Evan, G. I. ;

Kluk, M. J. ;

Bradner, J. E. ;

Aster, J. C. ;

French, C. A. .

ONCOGENE, 2014, 33 (13) :1736-1742

[19] A Single Oncogenic Enhancer Rearrangement Causes Concomitant EVI1 and GATA2 Deregulation in Leukemia [J].

Groeschel, Stefan ;

Sanders, Mathijs A. ;

Hoogenboezem, Remco ;

de Wit, Elzo ;

Bouwman, Britta A. M. ;

Erpelinck, Claudia ;

van der Velden, Vincent H. J. ;

Havermans, Marije ;

Avellino, Roberto ;

van Lom, Kirsten ;

Rombouts, Elwin J. ;

van Duin, Mark ;

Doehner, Konstanze ;

Beverloo, H. Berna ;

Bradner, James E. ;

Doehner, Hartmut ;

Lowenberg, Bob ;

Valk, Peter J. M. ;

Bindels, Eric M. J. ;

de Laat, Wouter ;

Delwel, Ruud .

CELL, 2014, 157 (02) :369-381

[20] Nucleophosmin interacts with HEXIM1 and regulates RNA polymerase II transcription [J].

Gurumurthy, Meera ;

Tan, Chuan Hao ;

Ng, Raymond ;

Zeiger, Lisa ;

Lau, Joanne ;

Lee, Jialing ;

Dey, Anwesha ;

Philp, Robin ;

Li, Qintong ;

Lim, Tit Meng ;

Price, David H. ;

Lane, David P. ;

Chao, Sheng-Hao .

JOURNAL OF MOLECULAR BIOLOGY, 2008, 378 (02) :302-317

← 1 2 3 4 →